Our Annual Biotech Review/Preview with STAT’s Adam Feuerstein

We spend a lot of time on The Bio Report talking about innovation. We are living at a time of great scientific advances that are translating into remarkable therapies that are changing people’s lives. Sometimes, though, the type of innovation needed to address a global health problem has more to do with access and delivery than technology. This was brought home to me when my friend Menghis Bairu, an Eritrean-born physician, life sciences executive, and philanthropist, returned from a recent trip. Menghis had gone to Ethiopia and Eritrea, where he worked with the Himalayan Cataract Project. HCP is working to eradicate curable blindness. There are some 18 million people in the developing world who are unable to perform the tasks of daily living because of easily treatable cataracts that can be addressed with a fast and inexpensive procedure. During a one-week period in these countries, the organization performed nearly 4,500 sight-saving surgeries and provided training to doctors in there. We spoke to Matt Oliva, associate clinical professor in the division of international ophthalmology at the Casey Eye Institute and Oregon Health Sciences University, and a member of the Himalayan Cataract Project board who is involved in the clinical and programmatic direction of HCPs outreach in Ethiopia, about the burden of blindness in the developing world, the global health need HCP is addressing, and its model for delivering care and training to cure preventable blindness. We’re doing this special edition of The Bio Report podcast to help Menghis’ fundraising efforts to bring HCP back to Ethiopia and Eritrea in 2020. The campaign is seeking to raise $100,000. We’ve provided a link to the GoFundMe campaign (https://charity.gofundme.com/o/en/campaign/giving-the-gift-of-sight-in-ethiopia-and-eritrea). We encourage all of our listeners to consider making a contribution to support the effort.